G. Fuchs

1.8k total citations
38 papers, 1.4k citations indexed

About

G. Fuchs is a scholar working on Neurology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, G. Fuchs has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Neurology, 12 papers in Cellular and Molecular Neuroscience and 7 papers in Psychiatry and Mental health. Recurrent topics in G. Fuchs's work include Parkinson's Disease Mechanisms and Treatments (32 papers), Neurological disorders and treatments (20 papers) and Genetic Neurodegenerative Diseases (7 papers). G. Fuchs is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (32 papers), Neurological disorders and treatments (20 papers) and Genetic Neurodegenerative Diseases (7 papers). G. Fuchs collaborates with scholars based in Germany, Sweden and United Kingdom. G. Fuchs's co-authors include Alexander Storch, Wolfgang H. Jost, Georg Ebersbach, Per Odin, Heinz Reichmann, W. Kuhn, К. Ray Chaudhuri, Christine Schneider, David Emmans and Rainer Koch and has published in prestigious journals such as Neurology, Annals of Neurology and Movement Disorders.

In The Last Decade

G. Fuchs

34 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Fuchs Germany 17 1.0k 387 248 191 146 38 1.4k
Margery H. Mark United States 19 895 0.9× 238 0.6× 200 0.8× 180 0.9× 189 1.3× 31 1.1k
Stephen Grill United States 17 1.0k 1.0× 250 0.6× 413 1.7× 211 1.1× 273 1.9× 29 1.5k
Stacy Horn United States 13 1.1k 1.1× 226 0.6× 298 1.2× 117 0.6× 245 1.7× 19 1.5k
Francesca Assogna Italy 26 967 0.9× 240 0.6× 485 2.0× 160 0.8× 292 2.0× 55 1.8k
Katie Kompoliti United States 24 979 0.9× 521 1.3× 234 0.9× 179 0.9× 297 2.0× 56 1.9k
Anna Sauerbier United Kingdom 23 1.4k 1.4× 253 0.7× 228 0.9× 143 0.7× 115 0.8× 56 1.6k
Karina Bienfait United States 15 824 0.8× 193 0.5× 289 1.2× 159 0.8× 148 1.0× 17 1.1k
Giulio Riboldazzi Italy 18 1.1k 1.0× 358 0.9× 171 0.7× 257 1.3× 261 1.8× 35 1.5k
M Doder United Kingdom 8 1.2k 1.1× 599 1.5× 346 1.4× 124 0.6× 126 0.9× 13 1.5k
Zoe Katsarou Greece 22 724 0.7× 191 0.5× 321 1.3× 150 0.8× 109 0.7× 74 1.3k

Countries citing papers authored by G. Fuchs

Since Specialization
Citations

This map shows the geographic impact of G. Fuchs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Fuchs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Fuchs more than expected).

Fields of papers citing papers by G. Fuchs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Fuchs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Fuchs. The network helps show where G. Fuchs may publish in the future.

Co-authorship network of co-authors of G. Fuchs

This figure shows the co-authorship network connecting the top 25 collaborators of G. Fuchs. A scholar is included among the top collaborators of G. Fuchs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Fuchs. G. Fuchs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duvick, Lisa, et al.. (2025). An expanded polyglutamine in ATAXIN1 results in a loss-of-function that exacerbates severity of Multiple Sclerosis in an EAE mouse model. Journal of Neuroinflammation. 22(1). 127–127. 1 indexed citations
2.
Storch, Alexander, Christine Schneider, Per Odin, et al.. (2015). Quantitative assessment of non-motor fluctuations in Parkinson’s disease using the Non-Motor Symptoms Scale (NMSS). Journal of Neural Transmission. 122(12). 1673–1684. 54 indexed citations
3.
Eggert, Karla, Jan Kassubek, Martin Wolz, et al.. (2014). Influence of the Nonergot Dopamine Agonist Piribedil on Vigilance in Patients With Parkinson Disease and Excessive Daytime Sleepiness (PiViCog-PD). Clinical Neuropharmacology. 37(4). 116–122. 25 indexed citations
4.
Pilhatsch, Maximilian, Nils B. Kroemer, Christine Schneider, et al.. (2012). Reduced Body Mass Index in Parkinson’s Disease. The Journal of Nervous and Mental Disease. 201(1). 76–79. 15 indexed citations
5.
Schnitzler, Alfons, G. Fuchs, H. Baas, et al.. (2010). Brauchen wir die frühzeitige tiefe Hirnstimulation beim Morbus Parkinson?. Fortschritte der Neurologie · Psychiatrie. 78(S 01). S37–S40. 3 indexed citations
6.
Storch, Alexander, Per Odin, Iris Trender‐Gerhard, et al.. (2010). Non-motor Symptoms Questionnaire und Scale für das idiopathische Parkinson-Syndrom. Der Nervenarzt. 81(8). 980–985. 33 indexed citations
7.
Storch, Alexander, Christine Schneider, Georg Ebersbach, et al.. (2010). Depression beim idiopathischen Parkinson-Syndrom – Teil 2: Therapie und Management. Fortschritte der Neurologie · Psychiatrie. 78(8). 456–467. 4 indexed citations
8.
Dodel, Richard, Ilona Csóti, Georg Ebersbach, et al.. (2008). Lewy body dementia and Parkinson’s disease with dementia. Journal of Neurology. 255(S5). 39–47. 42 indexed citations
9.
Storch, Alexander, Georg Ebersbach, G. Fuchs, et al.. (2008). Depression beim idiopathischen Parkinson-Syndrom. Fortschritte der Neurologie · Psychiatrie. 76(12). 715–724. 19 indexed citations
10.
Müller, Thomas, et al.. (2006). Diagnostic aspects of early Parkinson’s disease. Journal of Neurology. 253(S4). iv29–iv31. 3 indexed citations
11.
Foerster, Friedrich, et al.. (2004). Tremor in Parkinson's disease: 24-hr monitoring with calibrated accelerometry.. PubMed. 44(3). 137–46. 28 indexed citations
12.
Lemke, Matthias, G. Fuchs, I Gemende, et al.. (2004). Depression and Parkinson?s disease. Journal of Neurology. 251(S6). VI/24–7. 132 indexed citations
13.
Brand, Matthias, Kirsten Labudda, Elke Kalbe, et al.. (2004). Decision‐Making Impairments in Patients with Parkinson’s Disease. Behavioural Neurology. 15(3-4). 77–85. 182 indexed citations
14.
Baas, H., G. Fuchs, I Gemende, et al.. (2002). Which factors influence therapeutic decisions in Parkinson's disease?. Journal of Neurology. 249(0). 1–1. 1 indexed citations
15.
Krüger, Rejko, Cornelia Hardt, Frank Tschentscher, et al.. (2000). Genetic analysis of immunomodulating factors in sporadic Parkinson's disease. Journal of Neural Transmission. 107(5). 553–562. 75 indexed citations
16.
Reichmann, Heinz, Ülrike Sommer, G. Fuchs, et al.. (2000). Workshop IV: Drug treatment guidelines for the long-term management of Parkinson's disease. Journal of Neurology. 247(S4). IV40–IV41. 8 indexed citations
17.
Vieira‐Saecker, Ana, W. Kuhn, Daniela Berg, et al.. (1999). Increased susceptibility to sporadic Parkinson's disease by a certain combined ?-synuclein/apolipoprotein E genotype. Annals of Neurology. 45(5). 611–617. 217 indexed citations
18.
Kuhn, W., Th. M�ller, M. Gerlach, et al.. (1996). Depression in Parkinson's disease: biogenic amines in CSF of ?de novo? patients. Journal of Neural Transmission. 103(12). 1441–1445. 47 indexed citations
19.
Kienzl, E., E. Sofić, K. A. Jellinger, et al.. (1990). Urinary dopamine sulfate: regulations and significance in neurological disorders. PubMed. 32. 471–479. 7 indexed citations
20.
Fuchs, G., et al.. (1954). [Further experiences in the treatment of pre-climacteric and climacteric hemorrhagic disorders with weak filtered radium].. PubMed. 14(4). 310–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margery H. Mark Breakdown of academic impact, for papers by Stephen Grill Breakdown of academic impact, for papers by Stacy Horn Breakdown of academic impact, for papers by Francesca Assogna Breakdown of academic impact, for papers by Katie Kompoliti Breakdown of academic impact, for papers by Anna Sauerbier Breakdown of academic impact, for papers by Karina Bienfait Breakdown of academic impact, for papers by Giulio Riboldazzi Breakdown of academic impact, for papers by M Doder Breakdown of academic impact, for papers by Zoe Katsarou
Rankless by CCL
2026